Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 23 Multiple Myeloma 9 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Glioma 8 Thyroid Neoplasms 7 Neoplasm Metastasis 7 Hematologic Neoplasms 6 Thyroid Carcinoma, Anaplastic 5 Lymphoma 5 Thyroid Cancer, Papillary 4 Pancreatic Neoplasms 4 Neurofibromatosis 1 4 Neoplasms 4 Lung Neoplasms 3 Brain Neoplasms 3 Astrocytoma 3 Adenocarcinoma, Follicular 3 Skin Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neurofibroma, Plexiform 2 Leukemia, Myelomonocytic, Juvenile 2 Histiocytosis, Langerhans-Cell 2 Glioblastoma 2 Colonic Neoplasms 2 Advanced Solid Tumors 2 Uveal Melanoma 1

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fever × trametinib × 1 year × Clear all

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡